The biotechnology company faces potential delays with several of its drug development programs. Eastman Kodak Co., down $4.15 to $10.73.
News
- Foot Locker, MGM rise; Reata, Kodak fall
- Radius Health: 2Q Earnings Snapshot
The biotechnology company posted revenue of $50.1 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected ...
- For Nirenberg, plan to use sales tax for San Antonio's economic recovery is familiar and risky
For Nirenberg, plan to use sales tax for San Antonio's economic recovery is ... jobs in medicine, bioscience, information technology and construction.
- Nirenberg: Building a new economy for San Antonio
The targeted industries — identified as areas of opportunity in a recent SA Works COVID job report — include manufacturing, aerospace, bioscience, ...
- Miami business to plead guilty in Vermont fraud case
He and three others were indicted over a failed plan to build a biotechnology plant in Newport using $200 million in foreign investors' money through ...